Support the efficient expression of global commercial value with API as the core
About Us
In the future, relying on the company's entire industry chain system, we will provide customers with one-stop solutions and provide high-quality products and services
Founded in 2001, Qirui Technology Group is one of the comprehensive medical and health industry groups with leading comprehensive strength and scale in Hubei Province. health industry chain.
The Group firmly establishes and practices the core values of "Quality and Responsibility", promotes the continuous upgrading of operation model, talent incentives, organizational design and system construction, stimulates the vitality of various elements, and integrates global resources. The transformation of an international research enterprise.
DEVELOPMENT PATH
Qirui Technology Group was established in 2001
PRODUCT CENTER
Support with API as the core
Terminal preparation
read more +
Biological fermentation
read more +
APIs and Excipients
read more +
Pharmaceutical intermediates
read more +2022-06-14
The medical device industry ushered in a period of opportunity!
In recent years, in order to focus on the actual development of the medical device industry and the needs of the public for equipment, my country is constantly promoting the improvement of the medical device legal and regulatory system to promote the healthy and orderly development of the medical device industry.
2022-06-14
To achieve the "double carbon" goal, what can the medical device industry do?
The goals of "carbon peaking" and "carbon neutrality" proposed on September 22, 020 have aroused positive responses from all over the country. The greenhouse gases emitted by humans mainly come from fossil energy consumption (such as industrial manufacturing and transportation). Although the medical device industry is not an institution with high carbon emissions, it should also assume corresponding responsibilities. How can we do it? Let's take a look.
2022-06-14
What is the future of the medical device industry?
Recently, the Guangdong Provincial Food and Drug Administration issued the "List of Pilot Varieties of Medical Device Registrants in Guangdong Province". In the 61st item in the variety list, Huawei Terminal Co., Ltd., as the applicant registrant, applied for the medical device-wrist single-lead ECG. Collector (VID-B99). This means that at present, Huawei has obtained a registration certificate through the Guangdong Province registrant pilot, and it has become a fact that it has entered the field of medical devices. Huawei expands its layout in the medical device field According to the inquiry, the product registration number is Guangdong Machinery Registration 20202071705, the registrant is Huawei Terminal Co., Ltd., and the product management category is Category 2. The scope of application or intended use: for the collection of adult wrist single-lead ECG data. In fact, as a representative of domestic technology companies, Huawei has already begun to deploy in the medical field. According to the information from Tianyancha, Huawei Terminal Co., Ltd., which is actually controlled by Huawei Terminal (Shenzhen) Co., Ltd., changed the company's business scope on March 21, 2019, adding new businesses such as medical device (Class 2 medical device) sales. After the change, the business scope of Huawei Terminal Co., Ltd. is to develop, produce, and sell: communication and electronic products, computers, satellite TV receiving antennas, tuners and supporting products for the aforementioned products, and provide technical consultation and after-sales service; sales: medical Devices (Class 2 medical devices), etc. At the end of November 2019, the business of Deep Thinking Artificial Intelligence Robot Technology (Beijing) Co., Ltd. invested by Hubble Technology Investment Co., Ltd., a wholly-owned subsidiary of Huawei, also changed. Copy the device. At present, in addition to the field of medical equipment, Huawei also has different layouts in the fields of digital hospitals, regional health informatization, and hierarchical diagnosis and treatment. Industry insiders believe that as Huawei continues to compete in the medical field, in the future in the field of medical devices, it may also develop and produce representative works of domestically produced devices. Well-known companies have entered the medical equipment industry In fact, with the advancement of my country's hierarchical diagnosis and treatment policy, the number of beds and the number of patients in primary medical institutions continues to grow, and the demand for primary medical devices is increasing. The data shows that the overall market size of China's medical devices has grown from 255.6 billion yuan in 2014 to 530.4 billion yuan in 2018, with an average annual growth rate of around 20%, and both operating income and net profit have maintained rapid growth, which
QUALITY SYSTEM
Confidence that quality requirements will be met
GMP Certificate for Fasudil Mesylate
DGDA-1
DGDA-2
DGDA-3
WC certificate (posaconazole + tigecycline)
Hello, leave your thoughts
Please enter here
Contact us
Adresse: 12th Floor, Block A, 2008 New Changjiang Plaza, No. 2 Friendship Avenue, Wuchang District, Wuhan, Hubei, China
Tel: 4000-027-277
Tel：+86-027-88937598
E-mail: zysales@qrpharma.net
Copyright © 2023 Wuhan Qirui Pharmaceutical Co., Ltd. All Rights Reserved. Powered by www.300.cn SEO Business license
